New Delhi, May 23 -- Shares of Emcure Pharmaceuticals were locked in the 10 per cent upper circuit at Rs.1,288.65 on Friday, May 23, as the stock extended its rally to the second straight session. The rally comes on the back of a strong performance for the quarter ended March 2025 (Q4FY25). The stock had already surged nearly 9 per cent in the previous session, taking its total two-day gain to about 20 per cent.

As of the March 2025 quarter, Shark Tank judge Namita Vikas Thapar owns 50.71 lakh shares or a 2.68 per cent stake of the firm.

Emcure reported a 64 per cent year-on-year (YoY) jump in consolidated net profit to Rs.189 crore in Q4FY25, compared to Rs.115 crore in the same quarter last year. The revenue from operations rose 20 pe...